Hookipa Pharma

Developer of immunotherapies for the treatment of infectious diseases and cancer

placeVienna, Vienna, Austria calendar_todayFounded 2011 groups132 employees language hookipapharma.com

Registered entities

Investor mix

14 investors on record; lead investors include Redmile Group, Forbion, Sofinnova Partners, HBM Partners; 1 has since exited.

Investor typeCountShare
Venture capital643%
Private equity321%
Bank & private debt17%
Other / undisclosed429%
Coming soon